|Bid||65.62 x 900|
|Ask||65.99 x 3100|
|Day's range||65.64 - 66.84|
|52-week range||52.65 - 72.12|
|Beta (5Y monthly)||0.23|
|PE ratio (TTM)||103.11|
|Forward dividend & yield||1.45 (2.18%)|
|Ex-dividend date||11 Aug 2022|
|1y target est||76.71|
Volume growth from Amgen's (AMGN) key drugs like Prolia, Otezla, Repatha and others is expected to have been partially offset by biosimilar/generic competition for mature drugs.
Astrazeneca (AZN) closed at $66.28 in the latest trading session, marking a -1.97% move from the prior day.
AstraZeneca, NextEra Energy, The Boeing, The PNC Financial Services Group and Centene are part of the Zacks top Analyst Blog.